Particle.news
Download on the App Store

Back Pain Warning and Phase 1 KRAS Vaccine Trial Bolster Early Pancreatic Cancer Detection

Clinicians urge patients and GPs to heed persistent upper abdominal or back pain, with NHS screening pilots supporting new diagnostic pathways, preliminary vaccine trial results offering fresh hope for earlier treatment

Overview

  • Persistent upper abdominal or middle back pain that worsens when lying down or eating and improves on leaning forward is now emphasized as an early warning sign for pancreatic cancer.
  • Health experts advise patients to consult a GP if symptoms are sudden, persist for more than two weeks, or occur alongside other warning signs such as unexplained weight loss or jaundice.
  • The NHS has launched a record-search pilot in over 300 GP practices to identify high-risk individuals through new-onset diabetes and weight loss for earlier testing.
  • Phase 1 results of a KRAS-targeting vaccine trial published in Nature Medicine suggest slowed disease progression and longer-than-expected survival in a small patient cohort, though larger studies are required.
  • Some patients are exploring experimental local therapies, such as irreversible electroporation, as potential paths to operability, but these remain unproven pending further research.